 | • レポートコード：GIR-2104Z13381 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、スルファドキシンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。スルファドキシンの種類別市場規模（USP25、BP2000、その他）、用途別市場規模（溶血性連鎖球菌感染症、肺炎球菌感染症、髄膜炎菌感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・スルファドキシンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Jinshen Medical、Luotian Xinpusheng Pharmaceutical、Changshu Nanhu Industrial、Taicang Pharmaceutical Factory ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：USP25、BP2000、その他 ・用途別分析2016年-2026年：溶血性連鎖球菌感染症、肺炎球菌感染症、髄膜炎菌感染症、その他 ・スルファドキシンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・スルファドキシンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・スルファドキシンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・スルファドキシンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・スルファドキシンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sulfadoxine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Sulfadoxine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Sulfadoxine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Sulfadoxine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
USP25
BP2000
Other
Market segment by Application can be divided into
Hemolytic Streptococcal Infection
Pneumococcal Infection
Meningococcal Infection
Other
The key market players for global Sulfadoxine market are listed below:
Jinshen Medical
Luotian Xinpusheng Pharmaceutical
Changshu Nanhu Industrial
Taicang Pharmaceutical Factory
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Sulfadoxine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sulfadoxine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 USP25
1.2.3 BP2000
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Sulfadoxine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hemolytic Streptococcal Infection
1.3.3 Pneumococcal Infection
1.3.4 Meningococcal Infection
1.3.5 Other
1.4 Global Sulfadoxine Market Size & Forecast
1.4.1 Global Sulfadoxine Sales in Value (2016-2026))
1.4.2 Global Sulfadoxine Sales in Volume (2016-2026)
1.4.3 Global Sulfadoxine Price by Type (2016-2026) & (USD/MT)
1.5 Global Sulfadoxine Production Capacity Analysis
1.5.1 Global Sulfadoxine Total Production Capacity (2016-2026)
1.5.2 Global Sulfadoxine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sulfadoxine Market Drivers
1.6.2 Sulfadoxine Market Restraints
1.6.3 Sulfadoxine Trends Analysis
2 Manufacturers Profiles
2.1 Jinshen Medical
2.1.1 Jinshen Medical Details
2.1.2 Jinshen Medical Major Business
2.1.3 Jinshen Medical Sulfadoxine Product and Services
2.1.4 Jinshen Medical Sulfadoxine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Luotian Xinpusheng Pharmaceutical
2.2.1 Luotian Xinpusheng Pharmaceutical Details
2.2.2 Luotian Xinpusheng Pharmaceutical Major Business
2.2.3 Luotian Xinpusheng Pharmaceutical Sulfadoxine Product and Services
2.2.4 Luotian Xinpusheng Pharmaceutical Sulfadoxine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Changshu Nanhu Industrial
2.3.1 Changshu Nanhu Industrial Details
2.3.2 Changshu Nanhu Industrial Major Business
2.3.3 Changshu Nanhu Industrial Sulfadoxine Product and Services
2.3.4 Changshu Nanhu Industrial Sulfadoxine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Taicang Pharmaceutical Factory
2.4.1 Taicang Pharmaceutical Factory Details
2.4.2 Taicang Pharmaceutical Factory Major Business
2.4.3 Taicang Pharmaceutical Factory Sulfadoxine Product and Services
2.4.4 Taicang Pharmaceutical Factory Sulfadoxine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Sulfadoxine Sales by Manufacturer
3.1 Global Sulfadoxine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Sulfadoxine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Sulfadoxine
3.4 Market Concentration Rate
3.4.1 Top 3 Sulfadoxine Manufacturer Market Share
3.4.2 Top 6 Sulfadoxine Manufacturer Market Share
3.5 Global Sulfadoxine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Sulfadoxine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sulfadoxine Market Size by Region
4.1.1 Global Sulfadoxine Sales in Volume by Region (2016-2026)
4.1.2 Global Sulfadoxine Revenue by Region (2016-2026)
4.2 North America Sulfadoxine Revenue (2016-2026)
4.3 Europe Sulfadoxine Revenue (2016-2026)
4.4 Asia-Pacific Sulfadoxine Revenue (2016-2026)
4.5 South America Sulfadoxine Revenue (2016-2026)
4.6 Middle East and Africa Sulfadoxine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Sulfadoxine Sales in Volume by Type (2016-2026)
5.2 Global Sulfadoxine Revenue by Type (2016-2026)
5.3 Global Sulfadoxine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Sulfadoxine Sales in Volume by Application (2016-2026)
6.2 Global Sulfadoxine Revenue by Application (2016-2026)
6.3 Global Sulfadoxine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Sulfadoxine Sales by Type (2016-2026)
7.2 North America Sulfadoxine Sales by Application (2016-2026)
7.3 North America Sulfadoxine Market Size by Country
7.3.1 North America Sulfadoxine Sales in Volume by Country (2016-2026)
7.3.2 North America Sulfadoxine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Sulfadoxine Sales by Type (2016-2026)
8.2 Europe Sulfadoxine Sales by Application (2016-2026)
8.3 Europe Sulfadoxine Market Size by Country
8.3.1 Europe Sulfadoxine Sales in Volume by Country (2016-2026)
8.3.2 Europe Sulfadoxine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Sulfadoxine Sales by Type (2016-2026)
9.2 Asia-Pacific Sulfadoxine Sales by Application (2016-2026)
9.3 Asia-Pacific Sulfadoxine Market Size by Region
9.3.1 Asia-Pacific Sulfadoxine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Sulfadoxine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Sulfadoxine Sales by Type (2016-2026)
10.2 South America Sulfadoxine Sales by Application (2016-2026)
10.3 South America Sulfadoxine Market Size by Country
10.3.1 South America Sulfadoxine Sales in Volume by Country (2016-2026)
10.3.2 South America Sulfadoxine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sulfadoxine Sales by Type (2016-2026)
11.2 Middle East & Africa Sulfadoxine Sales by Application (2016-2026)
11.3 Middle East & Africa Sulfadoxine Market Size by Country
11.3.1 Middle East & Africa Sulfadoxine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Sulfadoxine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Sulfadoxine Typical Distributors
12.3 Sulfadoxine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Sulfadoxine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Sulfadoxine Revenue by Application, (USD Million), 2021-2026
Table 3. Jinshen Medical Basic Information, Manufacturing Base and Competitors
Table 4. Jinshen Medical Major Business
Table 5. Jinshen Medical Sulfadoxine Product and Services
Table 6. Jinshen Medical Sulfadoxine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Luotian Xinpusheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Luotian Xinpusheng Pharmaceutical Major Business
Table 9. Luotian Xinpusheng Pharmaceutical Sulfadoxine Product and Services
Table 10. Luotian Xinpusheng Pharmaceutical Sulfadoxine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Changshu Nanhu Industrial Basic Information, Manufacturing Base and Competitors
Table 12. Changshu Nanhu Industrial Major Business
Table 13. Changshu Nanhu Industrial Sulfadoxine Product and Services
Table 14. Changshu Nanhu Industrial Sulfadoxine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Taicang Pharmaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 16. Taicang Pharmaceutical Factory Major Business
Table 17. Taicang Pharmaceutical Factory Sulfadoxine Product and Services
Table 18. Taicang Pharmaceutical Factory Sulfadoxine Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Sulfadoxine Sales by Manufacturer (2019-2021e) & (MT)
Table 20. Global Sulfadoxine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Sulfadoxine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Sulfadoxine Production Capacity by Company, (MT): 2020 VS 2021
Table 23. Head Office and Sulfadoxine Production Site of Key Manufacturer
Table 24. Global Sulfadoxine Sales by Region (2016-2021e) & (MT)
Table 25. Global Sulfadoxine Sales by Region (2021-2026) & (MT)
Table 26. Global Sulfadoxine Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Sulfadoxine Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Sulfadoxine Sales by Type (2016-2021e) & (MT)
Table 29. Global Sulfadoxine Sales by Type (2021-2026) & (MT)
Table 30. Global Sulfadoxine Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Sulfadoxine Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Sulfadoxine Price by Type (2016-2021e) & (USD/MT)
Table 33. Global Sulfadoxine Price by Type (2021-2026) & (USD/MT)
Table 34. Global Sulfadoxine Sales by Application (2016-2021e) & (MT)
Table 35. Global Sulfadoxine Sales by Application (2021-2026) & (MT)
Table 36. Global Sulfadoxine Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Sulfadoxine Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Sulfadoxine Price by Application (2016-2021e) & (USD/MT)
Table 39. Global Sulfadoxine Price by Application (2021-2026) & (USD/MT)
Table 40. North America Sulfadoxine Sales by Country (2016-2021e) & (MT)
Table 41. North America Sulfadoxine Sales by Country (2021-2026) & (MT)
Table 42. North America Sulfadoxine Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Sulfadoxine Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Sulfadoxine Sales by Type (2016-2021e) & (MT)
Table 45. North America Sulfadoxine Sales by Type (2021-2026) & (MT)
Table 46. North America Sulfadoxine Sales by Application (2016-2021e) & (MT)
Table 47. North America Sulfadoxine Sales by Application (2021-2026) & (MT)
Table 48. Europe Sulfadoxine Sales by Country (2016-2021e) & (MT)
Table 49. Europe Sulfadoxine Sales by Country (2021-2026) & (MT)
Table 50. Europe Sulfadoxine Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Sulfadoxine Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Sulfadoxine Sales by Type (2016-2021e) & (MT)
Table 53. Europe Sulfadoxine Sales by Type (2021-2026) & (MT)
Table 54. Europe Sulfadoxine Sales by Application (2016-2021e) & (MT)
Table 55. Europe Sulfadoxine Sales by Application (2021-2026) & (MT)
Table 56. Asia-Pacific Sulfadoxine Sales by Region (2016-2021e) & (MT)
Table 57. Asia-Pacific Sulfadoxine Sales by Region (2021-2026) & (MT)
Table 58. Asia-Pacific Sulfadoxine Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Sulfadoxine Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Sulfadoxine Sales by Type (2016-2021e) & (MT)
Table 61. Asia-Pacific Sulfadoxine Sales by Type (2021-2026) & (MT)
Table 62. Asia-Pacific Sulfadoxine Sales by Application (2016-2021e) & (MT)
Table 63. Asia-Pacific Sulfadoxine Sales by Application (2021-2026) & (MT)
Table 64. South America Sulfadoxine Sales by Country (2016-2021e) & (MT)
Table 65. South America Sulfadoxine Sales by Country (2021-2026) & (MT)
Table 66. South America Sulfadoxine Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Sulfadoxine Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Sulfadoxine Sales by Type (2016-2021e) & (MT)
Table 69. South America Sulfadoxine Sales by Type (2021-2026) & (MT)
Table 70. South America Sulfadoxine Sales by Application (2016-2021e) & (MT)
Table 71. South America Sulfadoxine Sales by Application (2021-2026) & (MT)
Table 72. Middle East & Africa Sulfadoxine Sales by Country (2016-2021e) & (MT)
Table 73. Middle East & Africa Sulfadoxine Sales by Country (2021-2026) & (MT)
Table 74. Middle East & Africa Sulfadoxine Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Sulfadoxine Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Sulfadoxine Sales by Type (2016-2021e) & (MT)
Table 77. Middle East & Africa Sulfadoxine Sales by Type (2021-2026) & (MT)
Table 78. Middle East & Africa Sulfadoxine Sales by Application (2016-2021e) & (MT)
Table 79. Middle East & Africa Sulfadoxine Sales by Application (2021-2026) & (MT)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Sulfadoxine Typical Distributors
Table 83. Sulfadoxine Typical Customers
List of Figures
Figure 1. Sulfadoxine Picture
Figure 2. Global Sulfadoxine Sales Market Share by Type in 2020
Figure 3. USP25
Figure 4. BP2000
Figure 5. Other
Figure 6. Global Sulfadoxine Sales Market Share by Application in 2020
Figure 7. Hemolytic Streptococcal Infection
Figure 8. Pneumococcal Infection
Figure 9. Meningococcal Infection
Figure 10. Other
Figure 11. Global Sulfadoxine Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 12. Global Sulfadoxine Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Sulfadoxine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Sulfadoxine Sales (2016-2026) & (MT)
Figure 33. Global Sulfadoxine Production Capacity (2016-2026) & (MT)
Figure 34. Global Sulfadoxine Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Sulfadoxine Market Drivers
Figure 36. Sulfadoxine Market Restraints
Figure 37. Sulfadoxine Market Trends
Figure 38. Global Sulfadoxine Sales Market Share by Manufacturer in 2020
Figure 39. Global Sulfadoxine Revenue Market Share by Manufacturer in 2020
Figure 40. Sulfadoxine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Sulfadoxine Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Sulfadoxine Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Sulfadoxine Sales Market Share by Region (2016-2026)
Figure 44. Global Sulfadoxine Revenue Market Share by Region (2016-2026)
Figure 45. North America Sulfadoxine Revenue (2016-2026) & (USD Million)
Figure 46. Europe Sulfadoxine Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Sulfadoxine Revenue (2016-2026) & (USD Million)
Figure 48. South America Sulfadoxine Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Sulfadoxine Revenue (2016-2026) & (USD Million)
Figure 50. Global Sulfadoxine Sales Market Share by Type (2016-2026)
Figure 51. Global Sulfadoxine Revenue Market Share by Type (2016-2026)
Figure 52. Global Sulfadoxine Price by Type (2016-2026) & (USD/MT)
Figure 53. Global Sulfadoxine Sales Market Share by Application (2016-2026)
Figure 54. Global Sulfadoxine Revenue Market Share by Application (2016-2026)
Figure 55. Global Sulfadoxine Price by Application (2016-2026) & (USD/MT)
Figure 56. North America Sulfadoxine Sales Market Share by Country (2016-2026)
Figure 57. North America Sulfadoxine Revenue Market Share by Country (2016-2026)
Figure 58. North America Sulfadoxine Sales Market Share by Type (2016-2026)
Figure 59. North America Sulfadoxine Sales Market Share by Application (2016-2026)
Figure 60. Europe Sulfadoxine Sales Market Share by Country (2016-2026)
Figure 61. Europe Sulfadoxine Revenue Market Share by Country (2016-2026)
Figure 62. Europe Sulfadoxine Sales Market Share by Type (2016-2026)
Figure 63. Europe Sulfadoxine Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Sulfadoxine Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Sulfadoxine Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Sulfadoxine Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Sulfadoxine Sales Market Share by Application (2016-2026)
Figure 68. South America Sulfadoxine Sales Market Share by Country (2016-2026)
Figure 69. South America Sulfadoxine Revenue Market Share by Country (2016-2026)
Figure 70. South America Sulfadoxine Sales Market Share by Type (2016-2026)
Figure 71. South America Sulfadoxine Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Sulfadoxine Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Sulfadoxine Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Sulfadoxine Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Sulfadoxine Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のサイトメガロウイルス（CMV）感染市場規模・現状・予測（2021年-2027年） Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection c…- 世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 世界の菌血症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bloodstream Infection Testing Market The global Bloodstream Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の血液感染検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blood Infection Testing Market The global Blood Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の耳感染症治療市場規模・現状・予測（2021年-2027年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…